Dr. Talbots Cough Relief Liquid
NDC Package 70797-314-01
Package Information
Dr. Talbots Cough Relief (antimonium tartaricum, drosera rotundifolia, ipecacuanha, phosphorus, rumex crispus, spongia tosta, sticta pulmonaria, kali sulphuricum) liquids is shake before use, natural juice may settleMeasure only with the dosing syringe providedDo not use dosing syringe with other productsOn dosing syringe, weight is specific to productOn dosing syringe, ml = milliliter, lbs = pounds, kgs = kilogramsChildren under 6 months of age, consult a medical professional before using this product.For sudden onset of symptoms: Use every 15 minutes for up to 8 doses until symptoms relieved, then every 2 hours thereafter.Children 6 - 18 lbs or 3 - 8 kgs 1.25 ml every 2 hours, reduce frequency when symptoms improveChildren 19 - 29 lbs or 9 - 13 kgs 2.5 ml every 2 hours, reduce frequency when symptoms improveChildren 30 - 90 lbs or 14 - 41 kgs 5 ml every 2 hours, reduce frequency when symptoms improve. This formulation utilizes a liquid delivery system. Marketed by Talbot's Pharmaceuticals Family Products, Llc., this product is identified by NDC 70797-314.
Identification & Billing
Clinical Specifications
- ANTIMONY TARTRATE ION 12 [hp_X]/118mL
- DROSERA ROTUNDIFOLIA FLOWERING TOP 12 [hp_X]/118mL
- IPECAC 12 [hp_X]/118mL
- PHOSPHORUS 12 [hp_X]/118mL
- POTASSIUM SULFATE 6 [hp_X]/118mL
- PULMONARIA OFFICINALIS WHOLE 12 [hp_X]/118mL
- RUMEX CRISPUS ROOT 12 [hp_X]/118mL
- SPONGIA OFFICINALIS SKELETON, ROASTED 12 [hp_X]/118mL
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 70797 - Talbot's Pharmaceuticals Family Products, Llc.
- 70797-314 - Dr. Talbots Cough Relief
- 70797-314-01 - 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE (70797-314-04)
- 70797-314 - Dr. Talbots Cough Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70797-314-01 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle (70797-314-04) of Dr. Talbots Cough Relief, a human over the counter drug labeled by Talbot's Pharmaceuticals Family Products, Llc.. This liquid is formulated for oral use and contains antimony tartrate ion; drosera rotundifolia flowering top; ipecac; phosphorus; potassium sulfate; pulmonaria officinalis whole; rumex crispus root; spongia officinalis skeleton, roasted as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Talbot's Pharmaceuticals Family Products, Llc. on July 20, 2020. The current certification is valid through December 31, 2026.
How is this Talbot's Pharmaceuticals Family Products, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70797031401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.